The proportions of subjects with heart failure (all classes) and Class II heart failure were also higher in these three trials than the other trials, while the proportions of subjects with Class III heart failure were higher in SUSTAIN 6 and PIONEER 6 than the other trials
Download article citation: If you have the appropriate software installed, you can download article citation data to the citation manager of your choice
A study showed that individuals taking 1 mg and 2.4 mg injectable semaglutide over a 28-week timeframe lost 7% and 9.6% of their weight, respectively
With flexible scheduling and the use of secure digital health records, patients benefit from a streamlined process that fits into their daily lives while ensuring safe, evidence-based care
individuals should be aware of the legal, ethical, and health implications involved
As of January 2026 Medicaid programs in 13 states covered GLP-1 drugs for obesity